WallStSmart

DR Horton Inc (DHI)vsTaylor Morn Home (TMHC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

DR Horton Inc generates 313% more annual revenue ($33.52B vs $8.12B). DHI leads profitability with a 10.0% profit margin vs 9.6%. DHI appears more attractively valued with a PEG of 1.09. TMHC earns a higher WallStSmart Score of 59/100 (C).

DHI

Buy

55

out of 100

Grade: C

Growth: 4.7Profit: 6.0Value: 7.3Quality: 7.3
Piotroski: 3/9Altman Z: 5.10

TMHC

Buy

59

out of 100

Grade: C

Growth: 2.0Profit: 6.0Value: 7.3Quality: 7.3
Piotroski: 2/9
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

DHISignificantly Overvalued (-119.5%)

Margin of Safety

-119.5%

Fair Value

$74.66

Current Price

$137.69

$63.03 premium

UndervaluedFair: $74.66Overvalued
TMHCSignificantly Overvalued (-25.1%)

Margin of Safety

-25.1%

Fair Value

$52.50

Current Price

$59.52

$7.02 premium

UndervaluedFair: $52.50Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHI3 strengths · Avg: 8.7/10
Altman Z-ScoreHealth
5.1010/10

Safe zone — low bankruptcy risk

P/E RatioValuation
12.6x8/10

Attractively priced relative to earnings

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

TMHC2 strengths · Avg: 10.0/10
P/E RatioValuation
7.6x10/10

Attractively priced relative to earnings

Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Areas to Watch

DHI3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-9.5%2/10

Revenue declined 9.5%

EPS GrowthGrowth
-22.2%2/10

Earnings declined 22.2%

TMHC3 concerns · Avg: 2.3/10
Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-10.9%2/10

Revenue declined 10.9%

EPS GrowthGrowth
-23.4%2/10

Earnings declined 23.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : DHI

The strongest argument for DHI centers on Altman Z-Score, P/E Ratio, Price/Book. PEG of 1.09 suggests the stock is reasonably priced for its growth.

Bull Case : TMHC

The strongest argument for TMHC centers on P/E Ratio, Price/Book. PEG of 1.41 suggests the stock is reasonably priced for its growth.

Bear Case : DHI

The primary concerns for DHI are Piotroski F-Score, Revenue Growth, EPS Growth.

Bear Case : TMHC

The primary concerns for TMHC are Piotroski F-Score, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

TMHC carries more volatility with a beta of 1.56 — expect wider price swings.

DHI is growing revenue faster at -9.5% — sustainability is the question.

DHI generates stronger free cash flow (827M), providing more financial flexibility.

Monitor RESIDENTIAL CONSTRUCTION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TMHC scores higher overall (59/100 vs 55/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

DR Horton Inc

CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION · USA

D.R. Horton, Inc. is a home construction company incorporated in Delaware and headquartered in Arlington, Texas.

Taylor Morn Home

CONSUMER CYCLICAL · RESIDENTIAL CONSTRUCTION · USA

Taylor Morrison Home Corporation, is a public housing builder in the United States. The company is headquartered in Scottsdale, Arizona.

Visit Website →

Want to dig deeper into these stocks?